GlaxoSmithKline to invest in five new factories for Africa

By Bizclik Editor

The UK’s biggest drugs manufacturer, GlaxoSmithKline Plc, is set to announce today a multi-million pound plan to increase its presence in Sub-Saharan Africa.

The decision shows confidence in the growth of the continent as the global drugs company moves to take advantage of the opportunities in Africa.

Andrew Witty, Chief Executive Officer of GlaxoSmithKline, was reported saying in the Sunday Telegraph newspaper that the continent was important for the British company’s long-term growth.

He said: “The transformation of Africa into a successful growth region is one area that we need to focus on.”

The company is poised to build up to five new factories creating hundreds of new jobs and is actively seeking sites in Ghana, Ethiopia and Rwanda.

It already has production facilities in South Africa, Nigeria and Kenya which accounts for around £500 million of the group’s annual sales, which totalled £26.5 billion in 2013.

GSK’s African plan is set to be unveiled at the EU-Africa Business Summit in Brussels.


Featured Articles

Middle East GDP hike of 57% if more women join workforce

By tapping into the potential of next-generation female workers, the MENA region could unlock new economic opportunities, up to US$2 trillion, reports PwC

Dialight supplies LED solutions for industrial safety

Reliance on inefficient lighting technologies are not only harmful to the environment, but also increase injury risk and cost

Top 10: Tech, AI, cloud, cyber speakers at TECH LIVE LONDON

TECH LIVE LONDON events sees technology leaders from IBM, Oracle, Vodafone, JP Morgan, Accenture and the US Space Force among the inspirational speakers

Cyber LIVE adds Vodafone head of cyber Kawalec to line-up

Leadership & Strategy

Musk’s multibillion hostile Twitter takeover – the timeline

Leadership & Strategy

Sustainable moves businesses can make to win customers, IBM